FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+13.78%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.67B
AUM Growth
+$1.67B
(+11%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5
Top Buys
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$26.3M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$18.5M |
| 3 |
Alphatec Holdings
ATEC
|
$15.4M |
| 4 |
Relay Therapeutics
RLAY
|
$14.3M |
| 5 |
Insmed
INSM
|
$12.4M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$51.8M |
| 2 |
CareDx
CDNA
|
$29M |
| 3 |
BioXcel Therapeutics
BTAI
|
$15.5M |
| 4 |
Maravai LifeSciences
MRVI
|
$12.1M |
| 5 |
Health Catalyst
HCAT
|
$11.5M |
Sector Composition
| 1 | Healthcare | 83.7% |
| 2 | Communication Services | 4.44% |
| 3 | Energy | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fate Therapeutics
FATE
$115M
| $1.34M | 0.08% |
+15,400
| New | +$1.34M |
|
52
Integer Holdings
ITGR
$3.71B
| $551K | 0.03% |
5,846
| – | – |
|
|
NUVA
53
DELISTED
NuVasive, Inc.
NUVA
| $532K | 0.03% |
7,850
| – | – |
|
54
Waters Corp
WAT
$17.3B
| $531K | 0.03% |
1,536
| – | – |
|
55
Avantor
AVTR
$8.74B
| $518K | 0.03% |
14,596
| – | – |
|
|
SYNH
56
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $513K | 0.03% |
5,736
| – | – |
|
57
Envista
NVST
$3.37B
| $510K | 0.03% |
11,793
| – | – |
|
58
GSK
GSK
$79.3B
| $501K | 0.03% |
12,574
| – | – |
|
|
HRC
59
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $494K | 0.03% |
4,346
| – | – |
|
60
Bristol-Myers Squibb
BMY
$96.7B
| $485K | 0.03% |
7,256
| – | – |
|
61
Baxter International
BAX
$12.1B
| $477K | 0.03% |
5,929
| – | – |
|
62
Elevance Health
ELV
$72.4B
| $475K | 0.03% |
1,244
| – | – |
|
63
Humana
HUM
$37.5B
| $473K | 0.03% |
+1,068
| New | +$473K |
|
64
Gilead Sciences
GILD
$140B
| $462K | 0.03% |
6,705
| – | – |
|
65
CVS Health
CVS
$93B
| $461K | 0.03% |
5,519
| – | – |
|
66
Cigna
CI
$80.2B
| $461K | 0.03% |
1,943
| – | – |
|
67
Becton Dickinson
BDX
$54.3B
| $459K | 0.03% |
1,888
+226
| +14% | +$54.8K |
|
68
Perrigo
PRGO
$3.21B
| $450K | 0.03% |
9,823
| – | – |
|
69
United Therapeutics
UTHR
$17.7B
| $442K | 0.03% |
2,466
| – | – |
|
70
Takeda Pharmaceutical
TAK
$47.8B
| $431K | 0.03% |
+25,630
| New | +$431K |
|
71
AbbVie
ABBV
$374B
| $421K | 0.03% |
3,740
-2,241
| -37% | -$252K |
|
72
ICU Medical
ICUI
$3.06B
| $420K | 0.03% |
2,039
| – | – |
|
73
Hologic
HOLX
$14.7B
| $390K | 0.02% |
5,845
| – | – |
|
74
Johnson & Johnson
JNJ
$429B
| $356K | 0.02% |
2,161
| – | – |
|
75
Sanofi
SNY
$122B
| $350K | 0.02% |
6,650
| – | – |
|